Lakefront Biotherapeutics (LKFT) Non-cash Items (2014 - 2017)

Lakefront Biotherapeutics (LKFT) has 4 years of Non-cash Items data on file, last reported at -$26.5 million in Q2 2017.

• Non-cash Items for Q2 2017 came in at -$26.5 million, down 28.28% year-over-year; the trailing twelve-month figure through Jun 2017 was -$26.5 million (down 28.28% YoY), and the FY2015 annual result was -$89.4 million, down 174.85% from the prior year.
• Non-cash Items retreated to -$26.5 million in Q2 2017 per LKFT's latest filing, from -$7.9 million in the prior quarter.
• Over five years, Non-cash Items peaked at -$7.9 million in Q1 2017 and troughed at -$89.4 million in Q4 2015.
• A 4-year average of -$32.3 million and a median of -$23.6 million in 2016 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2015 and 2017: Non-cash Items plunged 174.85% in 2015, then jumped 52.88% in 2017.
• A 4-year view of Non-cash Items shows it stood at -$32.5 million in 2014, then sank by 174.85% to -$89.4 million in 2015, then soared by 76.87% to -$20.7 million in 2016, then fell by 28.28% to -$26.5 million in 2017.
• Business Quant data shows LKFT's Non-cash Items at -$26.5 million in Q2 2017, -$7.9 million in Q1 2017, and -$20.7 million in Q2 2016.